These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 10756725)
1. [The role of the endothelium in angiogenesis]. Dobrescu G Rev Med Chir Soc Med Nat Iasi; 1997; 101(1-2):31-9. PubMed ID: 10756725 [TBL] [Abstract][Full Text] [Related]
8. Ferulic acid augments angiogenesis via VEGF, PDGF and HIF-1 alpha. Lin CM; Chiu JH; Wu IH; Wang BW; Pan CM; Chen YH J Nutr Biochem; 2010 Jul; 21(7):627-33. PubMed ID: 19443196 [TBL] [Abstract][Full Text] [Related]
9. Nuclear factor kappaB dependency of platelet-activating factor-induced angiogenesis. Ko HM; Seo KH; Han SJ; Ahn KY; Choi IH; Koh GY; Lee HK; Ra MS; Im SY Cancer Res; 2002 Mar; 62(6):1809-14. PubMed ID: 11912159 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor and the regulation of angiogenesis. Ferrara N Recent Prog Horm Res; 2000; 55():15-35; discussion 35-6. PubMed ID: 11036931 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy. Wood JM Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930 [TBL] [Abstract][Full Text] [Related]
12. Essential role of PDGFRalpha-p70S6K signaling in mesenchymal cells during therapeutic and tumor angiogenesis in vivo: role of PDGFRalpha during angiogenesis. Tsutsumi N; Yonemitsu Y; Shikada Y; Onimaru M; Tanii M; Okano S; Kaneko K; Hasegawa M; Hashizume M; Maehara Y; Sueishi K Circ Res; 2004 May; 94(9):1186-94. PubMed ID: 15059936 [TBL] [Abstract][Full Text] [Related]
13. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor. Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116 [TBL] [Abstract][Full Text] [Related]
14. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis. de Jong JS; van Diest PJ; van der Valk P; Baak JP J Pathol; 1998 Jan; 184(1):53-7. PubMed ID: 9582527 [TBL] [Abstract][Full Text] [Related]
15. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584. Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977 [TBL] [Abstract][Full Text] [Related]